A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The study is comprised of two parts. The first portion of this study will be a double-blind,
Sponsor-unblinded, vehicle-controlled study with application of ruxolitinib or vehicle to
paired lesions at least 15 cm apart in patients with active but stable plaque psoriasis. Part
2 of the study is a double-blind, sponsor unblinded, comparison of ruxolitinib with two FDA
approved products in patients with active but stable plaque psoriasis.